Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
897
-
Total 13F shares, excl. options
-
253M
-
Shares change
-
+14.9M
-
Total reported value, excl. options
-
$18.8B
-
Value change
-
+$1.1B
-
Put/Call ratio
-
2.35
-
Number of buys
-
393
-
Number of sells
-
-391
-
Price
-
$74.27
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q1 2017
982 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q1 2017.
NOVARTIS AG - Ordinary Shares (NVS) has 897 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 253M shares
of 2.18B outstanding shares and own 11.61% of the company stock.
Largest 10 shareholders include DODGE & COX (50.6M shares), PRIMECAP MANAGEMENT CO/CA/ (21.7M shares), BROWN BROTHERS HARRIMAN & CO (10.8M shares), WELLS FARGO & COMPANY/MN (9.1M shares), PARNASSUS INVESTMENTS /CA (8.17M shares), BANK OF AMERICA CORP /DE/ (7.33M shares), LOOMIS SAYLES & CO L P (6.24M shares), Fisher Asset Management, LLC (6.12M shares), UBS Group AG (6M shares), and MANNING & NAPIER ADVISORS LLC (5M shares).
This table shows the top 897 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.